|
JAMA Dermatology |
Erythematous Plaque on the Lower Extremity of an Older Adult Man |
1 |
Yes |
6/29/2025 |
|
JAMA Dermatology |
Erythrokeratodermia |
1 |
Yes |
6/7/2024 |
|
JAMA Network Open |
Estimated Clinical Trial Capacity of Sites Participating in the COVID-19 Convalescent Plasma Expanded Access Program |
1 |
Yes |
10/26/2025 |
|
JAMA Network Open |
Estimated Effectiveness of COVID-19 Messenger RNA Vaccination Against SARS-CoV-2 Infection Among Older Male Veterans Health Administration Enrollees, January to September 2021 |
1 |
Yes |
12/21/2024 |
|
JAMA Network Open |
Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes |
1 |
Yes |
9/23/2025 |
|
JAMA |
Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021 |
1 |
Yes |
10/26/2025 |
|
JAMA Network Open |
Estimated Health Outcomes and Costs of COVID-19 Prophylaxis With Monoclonal Antibodies Among Unvaccinated Household Contacts in the US |
1 |
Yes |
4/22/2025 |
|
JAMA Network Open |
Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA Vaccinated and Nonvaccinated Individuals in Quebec, Canada |
1 |
Yes |
10/26/2025 |
|
JAMA Network Open |
Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic |
1 |
Yes |
8/4/2024 |
|
JAMA Pediatrics |
Estimated Transmission Outcomes and Costs of SARS-CoV-2 Diagnostic Testing, Screening, and Surveillance Strategies Among a Simulated Population of Primary School Students |
1 |
Yes |
4/22/2025 |
|
JAMA |
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021 |
1 |
Yes |
9/17/2024 |
|
JAMA Ophthalmology |
Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice |
1 |
Yes |
8/18/2024 |
|
JAMA Network Open |
Estimates of COVID-19 Cases and Deaths Among Nursing Home Residents Not Reported in Federal Data |
1 |
Yes |
9/17/2024 |
|
JAMA Network Open |
Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England |
1 |
Yes |
11/7/2025 |
|
JAMA |
Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada |
1 |
Yes |
3/7/2025 |
|
JAMA Network Open |
Estimating COVID-19 Infections, Hospitalizations, and Deaths Following the US Vaccination Campaigns During the Pandemic |
1 |
Yes |
1/14/2025 |
|
JAMA Network Open |
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States |
1 |
Yes |
10/26/2025 |
|
JAMA Network Open |
Estimation of Excess Mortality Rates Among US Assisted Living Residents During the COVID-19 Pandemic |
1 |
Yes |
6/21/2024 |
|
JAMA Network Open |
Estimation of the Timing and Intensity of Reemergence of Respiratory Syncytial Virus Following the COVID-19 Pandemic in the US |
1 |
Yes |
1/14/2025 |
|
Massachusetts Medical Society |
Ethics and Digital Health: Exploring the Ethics, Safety, and Privacy of Health and Wellbeing Apps and Devices (2021 MMS Ethics Forum) |
1.5 |
Yes |
5/26/2024 |
